Cutting-edge molecular tools are transforming the way cell therapy products are analyzed, offering faster, more sensitive, and less invasive testing methods compared to traditional approaches. This article explores how techniques like qPCR, NGS, and single-cell analyses streamline quality control, from identifying critical quality attributes to enabling quicker in-process decisions. Advanced molecular assays are driving greater efficiency and reliability, reducing time-to-release while maintaining product consistency and safety. The full article dives deeper into the strategies and technologies shaping the future of cell therapy testing.
Please check the highlighted fields and try again.
Please enter your first and last name.
Please enter the name of the company or institution you work at.
Please enter your mailing address.
By submitting this form, you consent to Cell & Gene Therapy Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.